• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Steroid-sparing medications in temporal arteritis--report of three cases and review of 174 reported patients.

作者信息

Nesher G, Sonnenblick M

机构信息

Division of Rheumatology, Saint Louis University School of Medicine, MO.

出版信息

Clin Rheumatol. 1994 Jun;13(2):289-92. doi: 10.1007/BF02249029.

DOI:10.1007/BF02249029
PMID:8088076
Abstract

More than half the patients with temporal arteritis experience steroid-related side effects, which are associated with increased morbidity and may shorten life expectancy. We describe 3 such patients, and our experience in tapering their steroid dosage with the use of dapsone or methotrexate. Based on our data and the review of 174 reported patients, it seems that no definite recommendation can be drawn regarding the use of steroid-sparing agents in temporal arteritis. There is a need for large controlled studies of several potential agents to evaluate their role in the treatment of this disease.

摘要

相似文献

1
Steroid-sparing medications in temporal arteritis--report of three cases and review of 174 reported patients.
Clin Rheumatol. 1994 Jun;13(2):289-92. doi: 10.1007/BF02249029.
2
Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?甲氨蝶呤能否作为一种糖皮质激素节约剂用于治疗风湿性多肌痛和巨细胞动脉炎？
Ann Rheum Dis. 1996 Apr;55(4):218-23. doi: 10.1136/ard.55.4.218.
3
A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).一项关于甲氨蝶呤治疗巨细胞动脉炎（GCA）的前瞻性、双盲、随机、安慰剂对照试验。
Clin Exp Rheumatol. 2001 Sep-Oct;19(5):495-501.
4
Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.甲氨蝶呤与泼尼松联合治疗巨细胞动脉炎：一项随机、双盲、安慰剂对照试验
Ann Intern Med. 2001 Jan 16;134(2):106-14. doi: 10.7326/0003-4819-134-2-200101160-00010.
5
Methotrexate treatment in the management of giant cell arteritis.甲氨蝶呤在巨细胞动脉炎治疗中的应用
Scand J Rheumatol. 1994;23(6):295-8. doi: 10.3109/03009749409099276.
6
Steroid-sparing effect and toxicity of dapsone treatment in giant cell arteritis: A single-center, retrospective study of 70 patients.氨苯砜治疗巨细胞动脉炎的激素节省效应及毒性：一项对70例患者的单中心回顾性研究。
Medicine (Baltimore). 2016 Oct;95(42):e4974. doi: 10.1097/MD.0000000000004974.
7
[Disulon in the treatment of Horton's disease. Experience with 20 patients].[双磺法治疗霍顿氏病。20例患者的经验]
Ann Med Interne (Paris). 1986;137(4):299-306.
8
[Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica].氨苯砜在治疗霍顿氏病和风湿性多肌痛中的作用
Ann Med Interne (Paris). 1984;135(1):31-5.
9
[Clinical course of Horton disease. Apropos of 42 cured patients].[霍顿病的临床病程。关于42例治愈患者]
Ann Med Interne (Paris). 1994;145(4):223-9.
10
[Prognosis of treated temporal arteritis. Retrospective study of 87 cases].[治疗后颞动脉炎的预后。87例回顾性研究]
Presse Med. 1986 Mar 29;15(13):603-6.

引用本文的文献

1
The Utility of Color Duplex Ultrasonography in the Diagnosis of Giant Cell Arteritis: A Prospective, Masked Study. (An American Ophthalmological Society Thesis).彩色双功超声在巨细胞动脉炎诊断中的应用：一项前瞻性、盲法研究。（美国眼科学会论文）
Trans Am Ophthalmol Soc. 2018 Jun 25;115:T9. eCollection 2017 Aug.
2
Treatment of vision loss in giant cell arteritis.巨细胞动脉炎所致视力丧失的治疗。
Curr Treat Options Neurol. 2012 Feb;14(1):84-92. doi: 10.1007/s11940-011-0152-7.
3
The treatment of giant cell arteritis.巨细胞动脉炎的治疗

本文引用的文献

1
The use of dapsone in the treatment of giant cell arteritis and polymyalgia rheumatica.氨苯砜在巨细胞动脉炎和风湿性多肌痛治疗中的应用。
Arthritis Rheum. 1983 May;26(5):689-90. doi: 10.1002/art.1780260521.
2
Prognosis in giant-cell arteritis.巨细胞动脉炎的预后
Br Med J (Clin Res Ed). 1981 Jan 24;282(6260):269-71. doi: 10.1136/bmj.282.6260.269.
3
Iatrogenic morbidity accompanying suppression of temporal arteritis by adrenal corticosteroids.肾上腺皮质类固醇抑制颞动脉炎所伴随的医源性发病率。
Rev Neurol Dis. 2008 Summer;5(3):140-52.
4
Giant cell arteritis.巨细胞动脉炎
Postgrad Med J. 2003 Sep;79(935):511-5. doi: 10.1136/pmj.79.935.511.
5
[Methotrexate therapy in rheumatologic diseases--an update].[甲氨蝶呤在风湿性疾病中的治疗——最新进展]
Wien Med Wochenschr. 2003;153(13-14):291-4. doi: 10.1046/j.1563-258x.2003.03034.x.
6
Recent advances in temporal arteritis.颞动脉炎的最新进展
Curr Pain Headache Rep. 2003 Aug;7(4):297-302. doi: 10.1007/s11916-003-0050-0.
Ann Ophthalmol. 1984 Mar;16(3):258-60, 262, 264-5.
4
[Results of a regional survey on the treatment of rhizomelic pseudopolyarthritis and temporal arteritis. Apropos of 242 cases treated by various modalities with synthetic antimalarials, corticoids and non-steroidal anti-inflammatory agents].
Rev Rhum Mal Osteoartic. 1983 Jul-Sep;50(8-9):563-71.
5
Cyclosporine: a new adjuvant therapy for giant cell arteritis?环孢素：巨细胞动脉炎的一种新辅助治疗方法？
Arthritis Rheum. 1985 Sep;28(9):1078-9. doi: 10.1002/art.1780280921.
6
[Disulon in the treatment of Horton's disease. Experience with 20 patients].[双磺法治疗霍顿氏病。20例患者的经验]
Ann Med Interne (Paris). 1986;137(4):299-306.
7
Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study.硫唑嘌呤治疗巨细胞动脉炎/风湿性多肌痛：一项双盲研究。
Ann Rheum Dis. 1986 Feb;45(2):136-8. doi: 10.1136/ard.45.2.136.
8
Long-term treatment of temporal arteritis with dapsone.用氨苯砜长期治疗颞动脉炎。
Am J Med. 1988 Sep;85(3):456-7. doi: 10.1016/0002-9343(88)90616-x.
9
Dapsone in temporal arteritis and polymyalgia rheumatica.
J Rheumatol. 1988;15(5):879-80.
10
Dapsone in the long-term treatment of temporal arteritis.氨苯砜用于颞动脉炎的长期治疗。
Am J Med. 1989 Jul;87(1):3. doi: 10.1016/s0002-9343(89)80471-1.